Pérez, A. I. R., Pedrosa, M. A., Labandeira, C. M., Valenzuela, R., Quijano, A., Sanchez-Andrade, M., . . . Labandeira-García, J. L. (2023). AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier.
Chicago-viite (17. p.)Pérez, Ana Isabel Rodríguez, María A. Pedrosa, Carmen M. Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, ja José Luis Labandeira-García. AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier, 2023.
MLA-viite (9. p.)Pérez, Ana Isabel Rodríguez, et al. AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier, 2023.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.